Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $475.7900 (-2.08%) ($473.2600 - $487.5200) on Sat. Jun. 10, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.83% (three month average) | RSI | 68 | Latest Price | $475.7900(-2.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 2.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting REGN price | REGN will decline at least -0.915% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.915% (StdDev 1.83%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
5 Day Moving Average | $480.34(-0.95%) | 10 Day Moving Average | $471.76(0.85%) | 20 Day Moving Average | $463.14(2.73%) | To recent high | -2.1% | To recent low | 30.3% | Market Cap | $N/A | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |